Performance of machine learning classifiers in classifying stunting among under-five children in Zambia ON Chilyabanyama, R Chilengi, M Simuyandi, CC Chisenga, M Chirwa, ... Children 9 (7), 1082, 2022 | 37 | 2022 |
Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants R Chilengi, K Mwila-Kazimbaya, M Chirwa, N Sukwa, C Chipeta, RM Velu, ... Vaccine 39 (27), 3633-3640, 2021 | 15 | 2021 |
Development of a diarrhoea severity scoring scale in a passive health facility-based surveillance system DT St Jean, ON Chilyabanyama, S Bosomprah, M Asombang, RM Velu, ... PLoS One 17 (8), e0272981, 2022 | 10 | 2022 |
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia J Mwaba, CC Chisenga, S Xiao, H Ng'ombe, E Banda, P Shea, ... Vaccine 39 (32), 4516-4523, 2021 | 8 | 2021 |
A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model R Chilengi, M Simuyandi, M Chibuye, M Chirwa, N Sukwa, N Laban, ... Vaccine 38 (46), 7357-7362, 2020 | 8 | 2020 |
Comparing growth velocity of HIV exposed and non-exposed infants: An observational study of infants enrolled in a randomized control trial in Zambia ON Chilyabanyama, R Chilengi, NM Laban, M Chirwa, M Simunyandi, ... Plos one 16 (8), e0256443, 2021 | 7 | 2021 |
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia EM Kunda-Ng'andu, M Simuyandi, M Kapulu, M Chirwa-Chobe, ... Wellcome Open Research 6, 2021 | 7 | 2021 |
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled … NM Laban, S Bosomprah, M Simuyandi, M Chibuye, A Chauwa, ... Vaccines 11 (2), 346, 2023 | 4 | 2023 |
Sickle cell disease in early infancy: a case report SGY Muzazu, M Chirwa, S Khatanga-Chihana, M Munyinda, M Simuyandi Pediatric Health, Medicine and Therapeutics, 377-383, 2022 | 1 | 2022 |
Exploring willingness to participate in future Human Infection Studies in Lusaka, Zambia: A nested qualitative exploratory study EM Kunda-Ngándu, M Chirwa-Chobe, C Mwamba, J Chipungu, ... Plos one 16 (7), e0254278, 2021 | 1 | 2021 |
The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia N Sukwa, S Bosomprah, P Somwe, M Muyoyeta, K Mwape, K Chibesa, ... Microorganisms 12 (4), 698, 2024 | | 2024 |
Maternal and Infant Histo-Blood Group Antigens (Hbga) Profiles and It’s Influence on Oral Rotavirus Vaccine (Rotarix®) Immunogenicity Among Infants in Zambia A Chauwa, NM Laban, S Bosomprah, B Phiri, M Chibuye, ... Preprints, 2023 | | 2023 |
Clinical presentation of congenital syphilis in a rotavirus vaccine cohort study in Lusaka: a case series N Sukwa, M Simuyandi, M Chirwa, YM Kumwimba, ON Chilyabanyama, ... Journal of Medical Case Reports 15, 1-9, 2021 | | 2021 |
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop i n Zambia [version 1; peer review: 2 approved] EM Kunda-Ng'andu, M Simuyandi, M Kapulu, M Chirwa-Chobe, ... | | 2021 |